TGFB1 and cancer: Numerous studies identified TGFβ1 as a key cytokine associated with the Epithelial-Mesenchymal Transition (EMT) program, which not only enables cancer cells to metastasize but also reduces their sensitivity to chemotherapeutic agents [25].